Regulations.gov document
Enzymatic Therapy, Inc. - BP Manager - Lycopene is a major nutrient for support of…
Other · FDA-1997-S-0039 · posted Jun 9, 2016
Key facts
| Document ID | FDA-1997-S-0039-2236 |
|---|---|
| Title | Enzymatic Therapy, Inc. - BP Manager - Lycopene is a major nutrient for support of cardiovascular health |
| Document type | Other |
| Subtype | 30 Day Structured Function Claim |
| Agency | FDA |
| Docket | FDA-1997-S-0039 |
| Posted | Jun 9, 2016 |
| Comment period opens | Jun 9, 2016 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: